Intellia Therapeutics Inc.

NTLA

Held by 2 specialist biotech funds

Share on X

Fund Holdings

Baker Bros. Advisors

Casdin Capital

Position history (shares)

Baker Bros. Advisors

3Q

3 quarters

Position Trend

May 15, 2025

$18.8M

2 funds

Aug 14, 2025

$25.1M

1 fund

Nov 14, 2025

$47.4M

1 fund

Feb 17, 2026

$0

0 funds

-100% total institutional value over 4 quarters

Short Interest

Short Shares

39.44M

Change

-12.9%

Days to Cover

9.9

% of Float

37.4%

Settlement

Mar 13, 2026

Short interest over 2 periods

Catalysts

No catalysts tracked.

Activist Filings

SC 13D/AOrbiMed Advisors5.0%Feb 16, 2018

SC 13D/AOrbiMed Advisors6.0%Jan 29, 2018

SC 13D/AOrbiMed Advisors6.0%Nov 8, 2017

Position Details

Baker Bros. AdvisorsEXITFeb 17, 2026

Shares: 2,746,674Value: $47.4M

Casdin CapitalEXITFeb 17, 2026

Shares: 0Value: N/A

+ 6more — see how much conviction went in

See the Full Story

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

ABSI2 funds CTNM2 funds DYN2 funds INCY2 funds GLUE2 funds GPCR2 funds BEIGF2 funds IPSC2 funds

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: